Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation | |
|---|---|---|
| D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.08 |
| D055371 | Acute Lung Injury NIH | 0.08 |
| D012128 | Respiratory Distress Syndrome, Adult NIH | 0.07 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Prospective observational trial in patients admitted to ICU diagnosed with COVID-19 requiring invasive mechanical ventilation. Characterization of Reverse Triggering asynchrony during the first 5 days of invasive mechanical ventilation and other asynchronies, and its correlation with different outcomes.
Description: To analyze the incidence of Reverse Triggering in the initial phases of invasive mechanical ventilation in COVID-19 patients
Measure: Incidence and pattern of presentation of Reverse triggering in COVID-19 patients under invasive mechanical ventilation Time: during the 5 first days of invasive mechanical ventilationDescription: To correlate the presence of Reverse Triggering with the level of sedation and use of neuromuscular blockers
Measure: Incidence of Reverse Triggering related to the level of sedation in COVID-19 patients under invasive mechanical ventilation Time: From the day of mechanical ventilation initation up to 5 days or the last day of mechanical ventilationDescription: To analyze the incidence of breath stacking and ineffective efforts secondary to RT.
Measure: Reverse triggering and secondary asynchronies in COVID-19 patients under invasive mechanical ventilation Time: From the day of mechanical ventilation initiation up to 5 daysDescription: To analyze the incidence of RT, ineffective efforts and double triggering throughout the period of invasive mechanical ventilation
Measure: Incidence and pattern of presentation of asynchronies in COVID-19 patients under invasive mechanical ventilation Time: Each day from the day of mechanical ventilation initiation until the day of mechanical ventilation withdrawal or up to 28 daysDescription: To correlate the presence of asycnhronies and its type with duration of invasive mechanical ventilation, ICU length of stay and survival
Measure: Influence of asynchronies in different outcomes in in COVID-19 patients under invasive mechanical ventilation Time: Each day from the day of mechanical ventilation initiation until the end of invasive mechanical ventilation, ICU discharge and hospital discharge or up to 28 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports